Cardiac Implantable Electronic and Other Monitoring Devices in Continuous-Flow Left Ventricular Assist Device Patients. A Clinical Consensus Statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

Q: What is the clinical evidence from this study?

Study design: Review. Population: Heart failure with continuous-flow left ventricular assist device (LVAD). Intervention: Cardiac implantable electronic devices (CIEDs) and monitoring devices.

Offer Amir; Stamatis Adamopoulos; Haran Burri; Antoni Bayés‐Genís; C. Leclercq; Maja Čikeš; Anastasia D. Egorova; Petr Peichl; Marat Fudim; Archana Rao; Finn Gustafsson; Sergio Richter; Matteo Pagnesi; Giuseppe M.C. Rosano; Frank Ruschitzka; Jens Cosedis Nielsen

doi:10.1002/ejhf.3635

April 1, 2025European Journal of Heart Failure

Cardiac Implantable Electronic and Other Monitoring Devices in Continuous-Flow Left Ventricular Assist Device Patients. A Clinical Consensus Statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC

View Full Paper

Ask AI

Bookmark

Share

Why the study?

Heart failure patients with continuous-flow LVADs frequently have CIEDs and coexisting arrhythmias, but large datasets and dedicated randomized controlled trials are lacking.

Key Points

Coexisting atrial arrhythmias and ventricular arrhythmias frequently complicate clinical care, creating substantial management challenges for specialized medical centers.
Approximately one third of these individuals carry cardiac implantable electronic devices, yet systematic outcome data remain limited across international registries.
Clinical consensus statement experts synthesize existing literature on continuous-flow left ventricular assist device recipients to align clinical management.
Calls for dedicated randomized controlled trials to establish standardized clinical protocols, addressing the current absence of robust multicenter datasets.

Structured PICO

P

Population

Heart failure patients with continuous-flow left ventricular assist devices (LVADs)

I

Intervention

Management of cardiac implantable electronic devices (CIEDs) and other monitoring devices

This consensus statement provides standardized guidance for the complex management of cardiac implantable electronic devices in patients with continuous-flow left ventricular assist devices.

Limitations

Lack of large datasets and dedicated randomized controlled trials focusing on LVAD and CIED implantation and management
Lack of large datasets
Lack of dedicated randomized controlled trials

Implication

Standardizes CIED and arrhythmia management in CF-LVAD patients; extends expert consensus to this high-prevalence population.

Abstract

The management of heart failure patients with continuous-flow left ventricular assist device (LVAD) patients is challenging. While one third of these patients are recipients of cardiac implantable electronic devices (CIEDs), the risk for atrial and ventricular arrhythmias may coexist. The lack of large datasets and dedicated randomized controlled trials (RCTs) focusing on LVAD and CIED implantation and management has brought medical centres to develop their own protocols and guidelines. This clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC is a joint effort to summarize the current literature and provide advice on patient management within this field.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Amir et al. (2025) conducted a review in Heart failure with continuous-flow left ventricular assist device (LVAD). Cardiac implantable electronic devices (CIEDs) and monitoring devices was evaluated. A clinical consensus statement provides guidance on the management of cardiac implantable electronic devices and arrhythmias in patients with continuous-flow left ventricular assist devices.

synapsesocial.com/papers/6a09ab1859b902245b45ffab https://doi.org/10.1002/ejhf.3635